Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market on Tuesday that its first quarter revenues grew 28 percent year over year.

For the three months ended March 31, total revenues were $23.1 million compared to $18.1 million in the prior-year period and surpassing the average Wall Street estimate of $21.6 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.